Background: The main purpose of this study is to provide a method for early diagnosis of Alzheimer’s disease. This disease reduces memory function by destroying neurons in the nervous system and reducing connections and neural interactions. Alzheimer’s disease is on the rise and there is no cure for it. With the help of medical image processing, Alzheimer’s disease is determined and the similarity of the characteristics of brain signals with medical images is determined. Methods: Then, by presenting the characteristics of effective brain signals, the mild Alzheimer’s group is determined. The level of this disease should be diagnosed according to the relationship between this disease and different features in the brain signal and medical images. Results: For 40 participants brain signals and MRI images were recorded during 4 phase protocol and after appropriate preprocessing, nonlinear properties such as phase diagram, correlation dimension, entropy, and Lyapunov exponential are extracted and classification is done using a convolutional neural network (CNN). The use of this deep learning method can have more appropriate and accurate results among other classification methods. Conclusions: The accuracy of the results in the reminding phase is 97.5% for the brain signal and 99% for the MRI images, which is an acceptable result.
Surface electromyography (sEMG) has been used for decades to diagnose movement and neuromuscular disorders; however, sEMG signals are noisy and interfered with, and the nonstationary, nonlinear nature of sEMG signals complicates their use for diagnostic purposes. However, existing denoising methods often sacrifice the original signal, thereby losing practical physiological details, which makes them clinically less applicable. To overcome these challenges, we introduce generalized successive variational mode decomposition (GSVMD), an advanced denoising technique that preserves signal integrity over all frequencies. GSVMD decouples Successive variational mode decomposition (SVMD) for adaptive signal decomposition, Soft interval thresholding (SIT) for focused noise reduction, and attention mechanisms to focus on clinically relevant signal components. GVSMD was evaluated using 4‐channel sEMG data from 12 healthy participants and 24 stroke patients, demonstrating superior performance compared to traditional methods, with a significant increase in SNR and R2 values. Its robustness was confirmed by statistical validation ( p < 0.001, p < 0.05). Taken together, these findings highlight GSVMD’s potential for real‐time clinical diagnostics and its potential application in a wide range of patient groups and conditions.
30 January 2026 in Biomedical Signal Processing and Control
Introduction: An unexpected number of people are at risk of Alzheimer's disease. Therefore, efforts to find effective preventive measures require to be intensified. Materials and Methods: To diagnose Alzheimer's disease through EEG signals using an artificial neural network, the first step involves pre-processing the recorded raw EEG data. This pre-processing ...